Chief Legal Officer
Douglas Snyder has served as GW Pharmaceuticals Chief Legal Officer since July 2017. He brings more than 20 years of experience providing counsel in the pharmaceutical industry, at the Food and Drug Administration (FDA) and in private practice. Prior to joining GW, Doug led the legal and compliance teams as Senior Vice President, General Counsel, and Secretary for Actelion US. Prior to that, Doug held the position of Senior Vice President, General Counsel, Secretary at Eisai Inc. where he led the Legal, Compliance, Legislative Affairs, Internal Audit and Security Group.
From 1999-2005, Doug was Vice-President, Associate General Counsel for GlaxoSmithKline. During his tenure at GSK, Doug managed the legal and communications strategies related to some of the company’s most high profile matters concerning the New York Attorney General, the U.S. department of Justice and the FDA.
Before joining the pharmaceutical industry, Doug held the role of Associate General Counsel for the FDA where he counseled the Commissioner, appeared before Congress in key initiatives, and led the initial False Claims/Kickback cases against the pharmaceutical industry.